Aquestive Therapeutics, Inc. AQST Personnel costs — Total Selling expenses

Other product segments

Similar metrics at other companies

GERNCommercial expenses — SG&A

$17M-15.0%

CRNXReportable Segment — Commercial Selling, General And Administrative Personnel Expenses

$20.04M+65.7%

HTF

HTFLSelling Expense

$18.93M+13.2%

FIGSSelling Expense

$36.44M+11.5%

DAKTSelling Expense

$16.59M+9.1%

VRTXPharmaceuticals — Selling and other commercial expenses

$313.6M+30.1%

Questions, answered.

What is Aquestive Therapeutics, Inc.'s personnel costs — total selling expenses?

Aquestive Therapeutics, Inc. (AQST) reported personnel costs — total selling expenses of $1.64M in Q1 2026.

How has Aquestive Therapeutics, Inc.'s personnel costs — total selling expenses changed year-over-year?

Aquestive Therapeutics, Inc.'s personnel costs — total selling expenses increased by 136.7% year-over-year, from $694K to $1.64M.

What is the long-term trend for Aquestive Therapeutics, Inc.'s personnel costs — total selling expenses?

Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s personnel costs — total selling expenses has grown at a 107.4% compound annual growth rate (CAGR), from $864K to $3.72M.

What does personnel costs — total selling expenses mean?

This metric captures the aggregate personnel-related costs associated with the sales and commercialization workforce. It includes salaries, commissions, and benefits for teams tasked with promoting and distributing the company's pharmaceutical products. Tracking this figure provides insight into the operational efficiency of the commercial organization and the cost of scaling market reach.